![](/images/2013/post-sep.jpg)
Post-Herpetic Neuralgia Treatment Market to Grow at 5.3% CAGR Through 2034, Says Fact.MR
Steady growth in the post-herpetic neuralgia treatment market is driven by rising cases and increasing demand for effective pain management solutions.
ROCKVILLE , MD, UNITED STATES, February 13, 2025 /EINPresswire.com/ -- According to a recent analysis by Fact.MR, the size of the post-herpetic neuralgia treatment market is expected to grow from US$ 822.4 million in 2024 to US$ 1.38 billion by the end of 2034. This translates to a 5.3% compound annual growth rate (CAGR) in the market between 2024 and 2034.
One kind of neuropathic pain brought on by an injury is called post-herpetic neuralgia (PHN). Recurrence of varicella-zoster virus often results in damage to peripheral nerves. Herpes zoster and shingles are caused by the virus. In regions with a single sensory nerve, neuralgia is more common.
Pain from post-herpetic neuralgia can linger for up to 85 days. In addition to PHN, a person may have multiple other health conditions. Examples include itching, strange sensations, pain with light touch, and hyperalgesia.
For More Insights into the Market, Request a Sample of this Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=10057
Large vendors vying for distribution and market share are driving the growth of the post-herpetic neuralgia therapy industry. Since there is currently no known cure for post-herpetic neuralgia, the main objective of treatment is to reduce symptoms.
What are the major trends shaping the post-herpetic neuralgia treatment market?
The market for postherpetic neuralgia treatment is expected to expand gradually due to advantageous reimbursement policies and growing awareness of the benefits of treatment. A increasing geriatric population and an increase in the prevalence of postherpetic neuralgia are also driving the global market.
It is anticipated that the government's support of treatment products and the growth of the healthcare infrastructure will create profitable prospects for treatment providers. Manufacturers are establishing trends in the treatment industry by creating new drugs to treat post-herpetic neuralgia.
The development of precision or customized medicine is being greatly aided by advances in biotechnology, which allow for more individualized treatment planning for each patient based on their genetic makeup or distinctive traits.
Enhancing the management of post-herpetic neuralgia is thought to need the incorporation of digital health technology, such as telemedicine, mobile health apps, and remote patient monitoring. These developments have the potential to improve patient outcomes, make healthcare more accessible, and produce useful research data.
Competitive Landscape
Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, Teva, Mylan, Hengrui Medicine, Acorda Therapeutics, Purdue Pharma L.P., Teikoku Pharma USA, Inc., and Janssen Pharmaceuticals, Inc. are major participants in the market for post-herpetic neuralgia treatments.
Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., and Endo Pharmaceuticals Inc. own over half of the revenue share of the global market for treating post-herpetic neuralgia.
In July 2022, Acasti Pharma declared that the pharmacokinetic trial for GTX-101, their medication candidate for the treatment of postherpetic neuralgia, has begun. Bupivacaine hydrochloride (HCl) in a unique formulation called GTX-101 is meant to be applied topically using a bioadhesive, film-forming polymer. It seeks to reduce the pain brought on by postherpetic neuralgia, a neuropathic pain disorder brought on by varicella-zoster virus-induced nerve injury (shingles). Bupivacaine hydrochloride (HCl) is applied topically using a bioadhesive film-forming polymer in the novel GTX-101 formulation, which is intended to give tailored relief.
Growth Drivers for Prepackaged Medical Kit and Tray Market
Increasing Focus on Infection Control: Rising awareness about the importance of infection prevention in healthcare settings is driving the demand for prepackaged medical kits and trays, which offer sterile, ready-to-use solutions.
Growth in Ambulatory and Home Healthcare: The expansion of ambulatory surgical centers and home healthcare services has increased the need for convenient, portable, and customized medical kits and trays.
Surge in Surgical Procedures: The growing number of surgical and diagnostic procedures globally, driven by an aging population and advancements in medical technology, is boosting the market for prepackaged medical solutions.
Time and Cost Efficiency: Prepackaged kits and trays help reduce procedure preparation time and minimize waste, leading to cost savings for healthcare providers, further fueling market adoption.
Regulatory Compliance and Quality Assurance: Stringent healthcare regulations emphasizing sterility and safety are encouraging the use of prepackaged solutions to ensure compliance and high-quality standards in patient care.
Technological Advancements: Innovations in packaging materials and customization options are enabling the development of more efficient, application-specific medical kits and trays, driving market growth.
Get Customization on this Report for Specific Research Solutions- https://www.factmr.com/connectus/sample?flag=S&rep_id=10057
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the ambulance cot market, presenting historical demand data (2018 to 2023) and forecast statistics for the period (2024 to 2034).
The study divulges essential insights into the market based on product (emergency cots, transport cots), technology (manual cots, pneumatic cots, electric cots), and end user (EMS service providers, hospitals, ambulatory service centers), across six major regions of the world (North America, Europe, East Asia, Latin America, South Asia & Oceania, and MEA).
Checkout More Related Studies Published by Fact.MR Research:
Herpes Markers Testing Market: The rising prevalence of herpes infections and continuous advancements in diagnostic technology are driving significant growth in the herpes marker testing market. With a strong pipeline of innovative testing solutions and active research efforts, healthcare providers are focusing on improving early diagnosis and disease management. The increasing emphasis on accurate and accessible testing is creating numerous opportunities for market players to expand their presence. As R&D activities continue to evolve, the herpes marker testing market is expected to witness steady expansion in the coming years.
Neuropathic Pain Market: The neuropathic pain market is experiencing steady growth, driven by advancements in nerve pain relief mechanisms and the development of more effective medications. Increasing demand for neuropathic pain relief drugs and related services is shaping the industry, as new treatments aim to address gaps in existing patient care. Continuous research and innovation in neurological pain management are expected to further expand market opportunities in the coming years.
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.
With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay competitive.
Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
S. N. Jha
Fact.MR
+1 628-251-1583
sales@factmr.com
![](https://supermarkets.einnews.com/tracking/article.gif?aid=785670389§ion=einpresswire&a=edYTaAWi982SGTkz&i=VDKQZgY5XnXgbKkp)
Distribution channels: Healthcare & Pharmaceuticals Industry
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release